Immunic Inc (IMUX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 03-2021 | 12-2020 | 09-2020 | 06-2020 | 03-2020 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -34,534 | -44,017 | -32,858 | -19,945 | -8,487 |
| Depreciation Amortization | 14 | 39 | 63 | 20 | 14 |
| Accounts payable and accrued liabilities | 6,773 | 1,000 | 875 | -676 | -973 |
| Other Working Capital | 8,863 | -2,365 | -795 | -1,053 | -2,909 |
| Other Operating Activity | 5,936 | -781 | 554 | 1,398 | 1,326 |
| Operating Cash Flow | $-12,948 | $-46,124 | $-32,161 | $-20,256 | $-11,029 |
| Cash Flows From Investing Activities | |||||
| PPE Investments | -10 | -146 | -122 | -59 | -4 |
| Investing Cash Flow | $-10 | $-146 | $-122 | $-59 | $-4 |
| Cash Flows From Financing Activities | |||||
| Common Stock Issued | 0 | 144,431 | 136,320 | 39,780 | 568 |
| Financing Cash Flow | $0 | $144,431 | $136,320 | $39,780 | $568 |
| Exchange Rate Effect | 345 | -78 | -223 | -227 | -326 |
| Beginning Cash Position | 127,452 | 29,369 | 29,369 | 29,369 | 29,369 |
| End Cash Position | 114,839 | 127,452 | 133,183 | 48,607 | 18,578 |
| Net Cash Flow | $-12,613 | $98,083 | $103,814 | $19,238 | $-10,791 |
| Free Cash Flow | |||||
| Operating Cash Flow | -12,948 | -46,124 | -32,161 | -20,256 | -11,029 |
| Capital Expenditure | -10 | -146 | -122 | -59 | -4 |
| Free Cash Flow | -12,958 | -46,270 | -32,283 | -20,315 | -11,033 |